Helen Margaret Shaw
Gründer bei Proveca Ltd.
Profil
Helen Margaret Shaw is the founder of Proveca Ltd.
which is founded in 2010, where she is currently the Medical Director.
She was also a former Chairman of NuVision Biotherapies Ltd.
and a former Non-Executive Director of Gunsynd Plc, Zilico Ltd., and Mode Diagnostics Ltd.
Additionally, she was a former Medical Director of Reckitt Benckiser Healthcare International Ltd.
from 1995 to 2003.
Aktive Positionen von Helen Margaret Shaw
Unternehmen | Position | Beginn |
---|---|---|
Proveca Ltd.
Proveca Ltd. Pharmaceuticals: MajorHealth Technology Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom. | Gründer | 01.07.2010 |
Ehemalige bekannte Positionen von Helen Margaret Shaw
Unternehmen | Position | Ende |
---|---|---|
GUNSYND PLC | Direktor/Vorstandsmitglied | 03.02.2010 |
Reckitt Benckiser Healthcare International Ltd.
Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
NuVision Biotherapies Ltd.
NuVision Biotherapies Ltd. Pharmaceuticals: MajorHealth Technology NuVision Biotherapies Ltd. commercializes biotherapies for treating ‘front of the eye’ disease and trauma. It offers Omnigen, an ‘off the shelf’, transportable biological matrix that can be used as an effective wound dressing for a range of indications including ocular surface indications. The firm also offers Tereo, a process that gently preserves the tissue such that it is stored in a dry state. The company was founded by Andrew Hopkinson in July 2014 and is headquartered in Nottingham, the United Kingdom. | Vorsitzender | - |
Mode Diagnostics Ltd.
Mode Diagnostics Ltd. Electronic Equipment/InstrumentsElectronic Technology Mode Diagnostics Ltd. develops medically informative health screening products. The company is headquartered in Glasgow, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GUNSYND PLC | Health Technology |
Private Unternehmen | 5 |
---|---|
Reckitt Benckiser Healthcare International Ltd.
Reckitt Benckiser Healthcare International Ltd. Household/Personal CareConsumer Non-Durables Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom. | Consumer Non-Durables |
Zilico Ltd.
Zilico Ltd. BiotechnologyHealth Technology Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Proveca Ltd.
Proveca Ltd. Pharmaceuticals: MajorHealth Technology Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom. | Health Technology |
Mode Diagnostics Ltd.
Mode Diagnostics Ltd. Electronic Equipment/InstrumentsElectronic Technology Mode Diagnostics Ltd. develops medically informative health screening products. The company is headquartered in Glasgow, the United Kingdom. | Electronic Technology |
NuVision Biotherapies Ltd.
NuVision Biotherapies Ltd. Pharmaceuticals: MajorHealth Technology NuVision Biotherapies Ltd. commercializes biotherapies for treating ‘front of the eye’ disease and trauma. It offers Omnigen, an ‘off the shelf’, transportable biological matrix that can be used as an effective wound dressing for a range of indications including ocular surface indications. The firm also offers Tereo, a process that gently preserves the tissue such that it is stored in a dry state. The company was founded by Andrew Hopkinson in July 2014 and is headquartered in Nottingham, the United Kingdom. | Health Technology |